nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—DDR2—eye—autistic disorder	0.00757	0.0233	CbGeAlD
Regorafenib—FGFR2—hindbrain—autistic disorder	0.00694	0.0213	CbGeAlD
Regorafenib—MAPK11—telencephalon—autistic disorder	0.00654	0.0201	CbGeAlD
Regorafenib—RAF1—hindbrain—autistic disorder	0.00639	0.0197	CbGeAlD
Regorafenib—FGFR2—mouth—autistic disorder	0.00609	0.0187	CbGeAlD
Regorafenib—DDR2—digestive system—autistic disorder	0.00527	0.0162	CbGeAlD
Regorafenib—EPHX2—eye—autistic disorder	0.00512	0.0157	CbGeAlD
Regorafenib—KIT—hindbrain—autistic disorder	0.00482	0.0148	CbGeAlD
Regorafenib—FLT4—eye—autistic disorder	0.00461	0.0142	CbGeAlD
Regorafenib—DDR2—head—autistic disorder	0.0043	0.0132	CbGeAlD
Regorafenib—KIT—mouth—autistic disorder	0.00423	0.013	CbGeAlD
Regorafenib—ABL1—hindbrain—autistic disorder	0.00419	0.0129	CbGeAlD
Regorafenib—FGFR1—telencephalon—autistic disorder	0.00415	0.0128	CbGeAlD
Regorafenib—DDR2—nervous system—autistic disorder	0.00408	0.0125	CbGeAlD
Regorafenib—MAPK11—head—autistic disorder	0.00408	0.0125	CbGeAlD
Regorafenib—FGFR2—brainstem—autistic disorder	0.00398	0.0122	CbGeAlD
Regorafenib—DDR2—central nervous system—autistic disorder	0.00392	0.0121	CbGeAlD
Regorafenib—FGFR2—eye—autistic disorder	0.00387	0.0119	CbGeAlD
Regorafenib—MAPK11—nervous system—autistic disorder	0.00386	0.0119	CbGeAlD
Regorafenib—FGFR2—forebrain—autistic disorder	0.00384	0.0118	CbGeAlD
Regorafenib—DDR2—cerebellum—autistic disorder	0.00384	0.0118	CbGeAlD
Regorafenib—MAPK11—central nervous system—autistic disorder	0.00372	0.0114	CbGeAlD
Regorafenib—RAF1—brainstem—autistic disorder	0.00366	0.0113	CbGeAlD
Regorafenib—MAPK11—cerebellum—autistic disorder	0.00364	0.0112	CbGeAlD
Regorafenib—FLT1—eye—autistic disorder	0.00359	0.011	CbGeAlD
Regorafenib—RAF1—eye—autistic disorder	0.00357	0.011	CbGeAlD
Regorafenib—RAF1—forebrain—autistic disorder	0.00354	0.0109	CbGeAlD
Regorafenib—FGFR2—telencephalon—autistic disorder	0.00353	0.0109	CbGeAlD
Regorafenib—TEK—telencephalon—autistic disorder	0.00338	0.0104	CbGeAlD
Regorafenib—PDGFRA—forebrain—autistic disorder	0.00333	0.0103	CbGeAlD
Regorafenib—FLT1—telencephalon—autistic disorder	0.00327	0.0101	CbGeAlD
Regorafenib—UGT1A9—digestive system—autistic disorder	0.00326	0.01	CbGeAlD
Regorafenib—RAF1—telencephalon—autistic disorder	0.00325	0.01	CbGeAlD
Regorafenib—DDR2—brain—autistic disorder	0.00312	0.00958	CbGeAlD
Regorafenib—PDGFRA—telencephalon—autistic disorder	0.00306	0.00943	CbGeAlD
Regorafenib—KDR—eye—autistic disorder	0.00303	0.00933	CbGeAlD
Regorafenib—KDR—forebrain—autistic disorder	0.00301	0.00925	CbGeAlD
Regorafenib—MAPK11—brain—autistic disorder	0.00295	0.00908	CbGeAlD
Regorafenib—RET—digestive system—autistic disorder	0.00283	0.00872	CbGeAlD
Regorafenib—KIT—brainstem—autistic disorder	0.00276	0.00849	CbGeAlD
Regorafenib—BRAF—cerebellum—autistic disorder	0.00271	0.00834	CbGeAlD
Regorafenib—FGFR2—digestive system—autistic disorder	0.00269	0.00828	CbGeAlD
Regorafenib—EPHA2—digestive system—autistic disorder	0.00265	0.00814	CbGeAlD
Regorafenib—PDGFRB—eye—autistic disorder	0.00262	0.00807	CbGeAlD
Regorafenib—FLT4—head—autistic disorder	0.00262	0.00806	CbGeAlD
Regorafenib—EPHX2—cerebellum—autistic disorder	0.00259	0.00797	CbGeAlD
Regorafenib—FLT1—digestive system—autistic disorder	0.0025	0.00768	CbGeAlD
Regorafenib—RAF1—digestive system—autistic disorder	0.00248	0.00763	CbGeAlD
Regorafenib—KIT—telencephalon—autistic disorder	0.00245	0.00754	CbGeAlD
Regorafenib—ABL1—brainstem—autistic disorder	0.0024	0.00739	CbGeAlD
Regorafenib—PDGFRB—telencephalon—autistic disorder	0.00239	0.00736	CbGeAlD
Regorafenib—ABL1—eye—autistic disorder	0.00234	0.0072	CbGeAlD
Regorafenib—PDGFRA—digestive system—autistic disorder	0.00234	0.0072	CbGeAlD
Regorafenib—RET—head—autistic disorder	0.00231	0.00711	CbGeAlD
Regorafenib—FGFR1—cerebellum—autistic disorder	0.00231	0.00709	CbGeAlD
Regorafenib—UGT1A1—digestive system—autistic disorder	0.00223	0.00686	CbGeAlD
Regorafenib—BRAF—brain—autistic disorder	0.0022	0.00677	CbGeAlD
Regorafenib—FGFR2—head—autistic disorder	0.0022	0.00676	CbGeAlD
Regorafenib—RET—nervous system—autistic disorder	0.00219	0.00674	CbGeAlD
Regorafenib—EPHA2—head—autistic disorder	0.00216	0.00664	CbGeAlD
Regorafenib—ABL1—telencephalon—autistic disorder	0.00213	0.00656	CbGeAlD
Regorafenib—RET—central nervous system—autistic disorder	0.00211	0.00649	CbGeAlD
Regorafenib—KDR—digestive system—autistic disorder	0.00211	0.00649	CbGeAlD
Regorafenib—TEK—head—autistic disorder	0.00211	0.00648	CbGeAlD
Regorafenib—EPHX2—brain—autistic disorder	0.0021	0.00647	CbGeAlD
Regorafenib—FGFR2—nervous system—autistic disorder	0.00208	0.00641	CbGeAlD
Regorafenib—RET—cerebellum—autistic disorder	0.00206	0.00634	CbGeAlD
Regorafenib—EPHA2—nervous system—autistic disorder	0.00205	0.0063	CbGeAlD
Regorafenib—FLT1—head—autistic disorder	0.00204	0.00626	CbGeAlD
Regorafenib—RAF1—head—autistic disorder	0.00202	0.00623	CbGeAlD
Regorafenib—FGFR2—central nervous system—autistic disorder	0.00201	0.00617	CbGeAlD
Regorafenib—TEK—nervous system—autistic disorder	0.002	0.00614	CbGeAlD
Regorafenib—EPHA2—central nervous system—autistic disorder	0.00197	0.00606	CbGeAlD
Regorafenib—FGFR2—cerebellum—autistic disorder	0.00196	0.00603	CbGeAlD
Regorafenib—FLT1—nervous system—autistic disorder	0.00193	0.00594	CbGeAlD
Regorafenib—TEK—central nervous system—autistic disorder	0.00192	0.00591	CbGeAlD
Regorafenib—RAF1—nervous system—autistic disorder	0.00192	0.0059	CbGeAlD
Regorafenib—PDGFRA—head—autistic disorder	0.00191	0.00587	CbGeAlD
Regorafenib—FLT4—brain—autistic disorder	0.0019	0.00584	CbGeAlD
Regorafenib—TEK—cerebellum—autistic disorder	0.00188	0.00578	CbGeAlD
Regorafenib—FGFR1—brain—autistic disorder	0.00187	0.00576	CbGeAlD
Regorafenib—KIT—digestive system—autistic disorder	0.00187	0.00575	CbGeAlD
Regorafenib—FLT1—central nervous system—autistic disorder	0.00186	0.00572	CbGeAlD
Regorafenib—RAF1—central nervous system—autistic disorder	0.00185	0.00568	CbGeAlD
Regorafenib—PDGFRB—digestive system—autistic disorder	0.00183	0.00562	CbGeAlD
Regorafenib—FLT1—cerebellum—autistic disorder	0.00182	0.00559	CbGeAlD
Regorafenib—PDGFRA—nervous system—autistic disorder	0.00181	0.00556	CbGeAlD
Regorafenib—RAF1—cerebellum—autistic disorder	0.00181	0.00556	CbGeAlD
Regorafenib—PDGFRA—central nervous system—autistic disorder	0.00174	0.00536	CbGeAlD
Regorafenib—KDR—head—autistic disorder	0.00172	0.00529	CbGeAlD
Regorafenib—PDGFRA—cerebellum—autistic disorder	0.0017	0.00524	CbGeAlD
Regorafenib—RET—brain—autistic disorder	0.00168	0.00515	CbGeAlD
Regorafenib—KDR—nervous system—autistic disorder	0.00163	0.00502	CbGeAlD
Regorafenib—ABL1—digestive system—autistic disorder	0.00163	0.00501	CbGeAlD
Regorafenib—FGFR2—brain—autistic disorder	0.00159	0.0049	CbGeAlD
Regorafenib—KDR—central nervous system—autistic disorder	0.00157	0.00483	CbGeAlD
Regorafenib—EPHA2—brain—autistic disorder	0.00156	0.00481	CbGeAlD
Regorafenib—KDR—cerebellum—autistic disorder	0.00154	0.00472	CbGeAlD
Regorafenib—TEK—brain—autistic disorder	0.00153	0.00469	CbGeAlD
Regorafenib—KIT—head—autistic disorder	0.00153	0.00469	CbGeAlD
Regorafenib—PDGFRB—head—autistic disorder	0.00149	0.00458	CbGeAlD
Regorafenib—FLT1—brain—autistic disorder	0.00148	0.00454	CbGeAlD
Regorafenib—RAF1—brain—autistic disorder	0.00147	0.00451	CbGeAlD
Regorafenib—KIT—nervous system—autistic disorder	0.00145	0.00445	CbGeAlD
Regorafenib—PDGFRB—nervous system—autistic disorder	0.00141	0.00434	CbGeAlD
Regorafenib—KIT—central nervous system—autistic disorder	0.00139	0.00428	CbGeAlD
Regorafenib—PDGFRA—brain—autistic disorder	0.00138	0.00425	CbGeAlD
Regorafenib—KIT—cerebellum—autistic disorder	0.00136	0.00419	CbGeAlD
Regorafenib—PDGFRB—central nervous system—autistic disorder	0.00136	0.00418	CbGeAlD
Regorafenib—ABCG2—telencephalon—autistic disorder	0.00134	0.00414	CbGeAlD
Regorafenib—PDGFRB—cerebellum—autistic disorder	0.00133	0.00409	CbGeAlD
Regorafenib—ABL1—head—autistic disorder	0.00133	0.00408	CbGeAlD
Regorafenib—ABL1—nervous system—autistic disorder	0.00126	0.00387	CbGeAlD
Regorafenib—KDR—brain—autistic disorder	0.00125	0.00384	CbGeAlD
Regorafenib—ABL1—central nervous system—autistic disorder	0.00121	0.00373	CbGeAlD
Regorafenib—CYP2C19—digestive system—autistic disorder	0.00121	0.00372	CbGeAlD
Regorafenib—ABL1—cerebellum—autistic disorder	0.00118	0.00364	CbGeAlD
Regorafenib—KIT—brain—autistic disorder	0.00111	0.0034	CbGeAlD
Regorafenib—PDGFRB—brain—autistic disorder	0.00108	0.00332	CbGeAlD
Regorafenib—ABL1—brain—autistic disorder	0.000962	0.00296	CbGeAlD
Regorafenib—CYP2B6—digestive system—autistic disorder	0.000947	0.00291	CbGeAlD
Regorafenib—CYP2C9—digestive system—autistic disorder	0.000938	0.00288	CbGeAlD
Regorafenib—CYP2B6—head—autistic disorder	0.000773	0.00238	CbGeAlD
Regorafenib—ABCG2—cerebellum—autistic disorder	0.000747	0.0023	CbGeAlD
Regorafenib—CYP2B6—nervous system—autistic disorder	0.000732	0.00225	CbGeAlD
Regorafenib—ABCB1—forebrain—autistic disorder	0.000721	0.00222	CbGeAlD
Regorafenib—CYP3A4—digestive system—autistic disorder	0.000715	0.0022	CbGeAlD
Regorafenib—CYP2B6—central nervous system—autistic disorder	0.000705	0.00217	CbGeAlD
Regorafenib—ABCB1—telencephalon—autistic disorder	0.000663	0.00204	CbGeAlD
Regorafenib—CYP2C8—brain—autistic disorder	0.000624	0.00192	CbGeAlD
Regorafenib—ABCG2—brain—autistic disorder	0.000607	0.00187	CbGeAlD
Regorafenib—CYP2B6—brain—autistic disorder	0.00056	0.00172	CbGeAlD
Regorafenib—CYP3A4—nervous system—autistic disorder	0.000553	0.0017	CbGeAlD
Regorafenib—CYP3A4—central nervous system—autistic disorder	0.000532	0.00164	CbGeAlD
Regorafenib—ABCB1—digestive system—autistic disorder	0.000506	0.00156	CbGeAlD
Regorafenib—ABCB1—head—autistic disorder	0.000413	0.00127	CbGeAlD
Regorafenib—ABCB1—nervous system—autistic disorder	0.000392	0.0012	CbGeAlD
Regorafenib—ABCB1—central nervous system—autistic disorder	0.000377	0.00116	CbGeAlD
Regorafenib—ABCB1—cerebellum—autistic disorder	0.000368	0.00113	CbGeAlD
Regorafenib—ABCB1—brain—autistic disorder	0.000299	0.00092	CbGeAlD
Regorafenib—FGFR1—Signaling Pathways—POMC—autistic disorder	1.07e-05	1.58e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—autistic disorder	1.07e-05	1.58e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.06e-05	1.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTEN—autistic disorder	1.06e-05	1.57e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTEN—autistic disorder	1.06e-05	1.57e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—XDH—autistic disorder	1.06e-05	1.57e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PRKCB—autistic disorder	1.05e-05	1.56e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNA1C—autistic disorder	1.05e-05	1.56e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—autistic disorder	1.05e-05	1.56e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—autistic disorder	1.05e-05	1.56e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DHFR—autistic disorder	1.05e-05	1.56e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SERPINE1—autistic disorder	1.05e-05	1.55e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—APOE—autistic disorder	1.04e-05	1.54e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—STX1A—autistic disorder	1.04e-05	1.54e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NPAS2—autistic disorder	1.04e-05	1.54e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PTEN—autistic disorder	1.03e-05	1.53e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—HRAS—autistic disorder	1.03e-05	1.53e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SERPINE1—autistic disorder	1.03e-05	1.52e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IGF1—autistic disorder	1.03e-05	1.52e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DHFR—autistic disorder	1.03e-05	1.52e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IGF1—autistic disorder	1.03e-05	1.52e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TSC2—autistic disorder	1.02e-05	1.51e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.01e-05	1.5e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—COMT—autistic disorder	1.01e-05	1.5e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTEN—autistic disorder	1.01e-05	1.5e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PIK3CG—autistic disorder	1.01e-05	1.5e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—APC—autistic disorder	1.01e-05	1.5e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GSTP1—autistic disorder	1.01e-05	1.49e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PTEN—autistic disorder	1.01e-05	1.49e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOA—autistic disorder	1.01e-05	1.49e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—MAPK1—autistic disorder	1e-05	1.49e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TCN2—autistic disorder	1e-05	1.49e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—MAPK1—autistic disorder	1e-05	1.48e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EGF—autistic disorder	9.98e-06	1.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LEP—autistic disorder	9.97e-06	1.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APOE—autistic disorder	9.97e-06	1.48e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	9.93e-06	1.47e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HRAS—autistic disorder	9.91e-06	1.47e-05	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HRAS—autistic disorder	9.91e-06	1.47e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—autistic disorder	9.88e-06	1.46e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—MAPK1—autistic disorder	9.85e-06	1.46e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CAT—autistic disorder	9.81e-06	1.45e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—autistic disorder	9.79e-06	1.45e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SERPINE1—autistic disorder	9.77e-06	1.45e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—autistic disorder	9.75e-06	1.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SERPINE1—autistic disorder	9.74e-06	1.44e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—autistic disorder	9.61e-06	1.42e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DHFR—autistic disorder	9.59e-06	1.42e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADA—autistic disorder	9.56e-06	1.42e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTEN—autistic disorder	9.54e-06	1.41e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—autistic disorder	9.49e-06	1.41e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PRKCB—autistic disorder	9.4e-06	1.39e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CG—autistic disorder	9.38e-06	1.39e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—MAPK1—autistic disorder	9.35e-06	1.39e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—MAPK1—autistic disorder	9.33e-06	1.38e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PLA2G4A—autistic disorder	9.26e-06	1.37e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GSTM1—autistic disorder	9.26e-06	1.37e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—MAPK1—autistic disorder	9.26e-06	1.37e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	9.24e-06	1.37e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—autistic disorder	9.24e-06	1.37e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP19A1—autistic disorder	9.22e-06	1.37e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTEN—autistic disorder	9.21e-06	1.37e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—autistic disorder	9.15e-06	1.36e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—MAPK1—autistic disorder	9.1e-06	1.35e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CG—autistic disorder	9e-06	1.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APC—autistic disorder	9e-06	1.33e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—autistic disorder	8.93e-06	1.32e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EGF—autistic disorder	8.89e-06	1.32e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GPX1—autistic disorder	8.87e-06	1.31e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	8.86e-06	1.31e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	8.78e-06	1.3e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HRAS—autistic disorder	8.77e-06	1.3e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—RORA—autistic disorder	8.72e-06	1.29e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MAPK1—autistic disorder	8.7e-06	1.29e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTEN—autistic disorder	8.69e-06	1.29e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.66e-06	1.28e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—MAPK1—autistic disorder	8.63e-06	1.28e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—MAPK1—autistic disorder	8.61e-06	1.28e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTEN—autistic disorder	8.61e-06	1.28e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—COMT—autistic disorder	8.58e-06	1.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—autistic disorder	8.56e-06	1.27e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GSTP1—autistic disorder	8.53e-06	1.26e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOA—autistic disorder	8.51e-06	1.26e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTEN—autistic disorder	8.51e-06	1.26e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—autistic disorder	8.48e-06	1.26e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—MAPK1—autistic disorder	8.4e-06	1.25e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—autistic disorder	8.4e-06	1.24e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—autistic disorder	8.4e-06	1.24e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—autistic disorder	8.4e-06	1.24e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—autistic disorder	8.33e-06	1.23e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAT—autistic disorder	8.3e-06	1.23e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IGF1—autistic disorder	8.24e-06	1.22e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP19A1—autistic disorder	8.23e-06	1.22e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MAPK1—autistic disorder	8.22e-06	1.22e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—MAPK1—autistic disorder	8.2e-06	1.21e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—MAPK1—autistic disorder	8.19e-06	1.21e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MTHFR—autistic disorder	8.19e-06	1.21e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOB—autistic disorder	8.17e-06	1.21e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	8.08e-06	1.2e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HRAS—autistic disorder	8.06e-06	1.19e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP19A1—autistic disorder	8.04e-06	1.19e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—HRAS—autistic disorder	8.02e-06	1.19e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—autistic disorder	7.98e-06	1.18e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—HRAS—autistic disorder	7.91e-06	1.17e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—autistic disorder	7.9e-06	1.17e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—autistic disorder	7.88e-06	1.17e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	7.84e-06	1.16e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GSTM1—autistic disorder	7.84e-06	1.16e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—autistic disorder	7.84e-06	1.16e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SERPINE1—autistic disorder	7.82e-06	1.16e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—MAPK1—autistic disorder	7.76e-06	1.15e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	7.73e-06	1.15e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—autistic disorder	7.71e-06	1.14e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—autistic disorder	7.68e-06	1.14e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—COMT—autistic disorder	7.65e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOE—autistic disorder	7.62e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTP1—autistic disorder	7.62e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOA—autistic disorder	7.6e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TPH2—autistic disorder	7.6e-06	1.13e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—autistic disorder	7.57e-06	1.12e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GPX1—autistic disorder	7.51e-06	1.11e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HRAS—autistic disorder	7.51e-06	1.11e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP19A1—autistic disorder	7.51e-06	1.11e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MAPK1—autistic disorder	7.49e-06	1.11e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HRAS—autistic disorder	7.49e-06	1.11e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DPYD—autistic disorder	7.47e-06	1.11e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—COMT—autistic disorder	7.47e-06	1.11e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—autistic disorder	7.44e-06	1.1e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—HRAS—autistic disorder	7.44e-06	1.1e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTP1—autistic disorder	7.44e-06	1.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—autistic disorder	7.42e-06	1.1e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOA—autistic disorder	7.42e-06	1.1e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—autistic disorder	7.41e-06	1.1e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—autistic disorder	7.32e-06	1.09e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—autistic disorder	7.32e-06	1.09e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—HRAS—autistic disorder	7.3e-06	1.08e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—autistic disorder	7.24e-06	1.07e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—autistic disorder	7.19e-06	1.06e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—autistic disorder	7.17e-06	1.06e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—autistic disorder	7.12e-06	1.06e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—autistic disorder	7.12e-06	1.05e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—autistic disorder	7.1e-06	1.05e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAPK1—autistic disorder	7.07e-06	1.05e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	7.05e-06	1.04e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PLA2G4A—autistic disorder	7e-06	1.04e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTM1—autistic disorder	7e-06	1.04e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAPK1—autistic disorder	7e-06	1.04e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—autistic disorder	6.99e-06	1.04e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HRAS—autistic disorder	6.98e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—COMT—autistic disorder	6.98e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNA1C—autistic disorder	6.95e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTP1—autistic disorder	6.95e-06	1.03e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—HRAS—autistic disorder	6.93e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—autistic disorder	6.93e-06	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOA—autistic disorder	6.93e-06	1.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—MAPK1—autistic disorder	6.92e-06	1.02e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—HRAS—autistic disorder	6.91e-06	1.02e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CG—autistic disorder	6.88e-06	1.02e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PLA2G4A—autistic disorder	6.83e-06	1.01e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTM1—autistic disorder	6.83e-06	1.01e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—autistic disorder	6.76e-06	1e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HRAS—autistic disorder	6.75e-06	1e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GPX1—autistic disorder	6.7e-06	9.93e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	6.68e-06	9.9e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—autistic disorder	6.68e-06	9.9e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—autistic disorder	6.63e-06	9.83e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—autistic disorder	6.62e-06	9.81e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HRAS—autistic disorder	6.6e-06	9.77e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HRAS—autistic disorder	6.58e-06	9.75e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HRAS—autistic disorder	6.57e-06	9.74e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—autistic disorder	6.55e-06	9.7e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GPX1—autistic disorder	6.54e-06	9.7e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAPK1—autistic disorder	6.49e-06	9.61e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—autistic disorder	6.46e-06	9.57e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOE—autistic disorder	6.45e-06	9.56e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PLA2G4A—autistic disorder	6.38e-06	9.46e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTM1—autistic disorder	6.38e-06	9.46e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAPK1—autistic disorder	6.37e-06	9.44e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—autistic disorder	6.33e-06	9.38e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DHFR—autistic disorder	6.32e-06	9.37e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—autistic disorder	6.31e-06	9.36e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—autistic disorder	6.3e-06	9.33e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—autistic disorder	6.29e-06	9.32e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—HRAS—autistic disorder	6.23e-06	9.23e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—autistic disorder	6.21e-06	9.21e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—autistic disorder	6.19e-06	9.17e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GPX1—autistic disorder	6.11e-06	9.06e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAPK1—autistic disorder	6.05e-06	8.96e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—autistic disorder	6.04e-06	8.95e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAPK1—autistic disorder	6.03e-06	8.94e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HRAS—autistic disorder	6.01e-06	8.91e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—autistic disorder	5.96e-06	8.83e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—autistic disorder	5.96e-06	8.83e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CG—autistic disorder	5.82e-06	8.63e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOE—autistic disorder	5.76e-06	8.53e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—autistic disorder	5.76e-06	8.53e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HRAS—autistic disorder	5.67e-06	8.41e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—autistic disorder	5.64e-06	8.36e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOE—autistic disorder	5.62e-06	8.33e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HRAS—autistic disorder	5.62e-06	8.33e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—HRAS—autistic disorder	5.55e-06	8.23e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—autistic disorder	5.54e-06	8.21e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	5.43e-06	8.05e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—autistic disorder	5.43e-06	8.04e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—autistic disorder	5.38e-06	7.97e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—autistic disorder	5.31e-06	7.87e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOE—autistic disorder	5.25e-06	7.78e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—autistic disorder	5.22e-06	7.74e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HRAS—autistic disorder	5.21e-06	7.72e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CG—autistic disorder	5.2e-06	7.7e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HRAS—autistic disorder	5.11e-06	7.58e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CG—autistic disorder	5.07e-06	7.52e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—autistic disorder	4.98e-06	7.39e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.95e-06	7.34e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—autistic disorder	4.95e-06	7.33e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—autistic disorder	4.9e-06	7.25e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HRAS—autistic disorder	4.85e-06	7.19e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAPK1—autistic disorder	4.84e-06	7.18e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HRAS—autistic disorder	4.84e-06	7.17e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—autistic disorder	4.83e-06	7.16e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CG—autistic disorder	4.74e-06	7.02e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—autistic disorder	4.65e-06	6.88e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—autistic disorder	4.63e-06	6.87e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—COMT—autistic disorder	4.6e-06	6.82e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTP1—autistic disorder	4.58e-06	6.79e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOA—autistic disorder	4.57e-06	6.77e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—autistic disorder	4.55e-06	6.75e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—autistic disorder	4.51e-06	6.69e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—autistic disorder	4.46e-06	6.61e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—autistic disorder	4.42e-06	6.55e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	4.36e-06	6.46e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTM1—autistic disorder	4.21e-06	6.24e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4.21e-06	6.24e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—autistic disorder	4.17e-06	6.19e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GPX1—autistic disorder	4.03e-06	5.97e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—autistic disorder	3.95e-06	5.85e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HRAS—autistic disorder	3.89e-06	5.76e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—autistic disorder	3.86e-06	5.71e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—autistic disorder	3.85e-06	5.71e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—autistic disorder	3.72e-06	5.51e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—autistic disorder	3.72e-06	5.51e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—autistic disorder	3.6e-06	5.33e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOE—autistic disorder	3.46e-06	5.13e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—autistic disorder	3.44e-06	5.1e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—autistic disorder	3.36e-06	4.98e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—autistic disorder	3.14e-06	4.65e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.13e-06	4.63e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—autistic disorder	2.98e-06	4.41e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—autistic disorder	2.37e-06	3.52e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—autistic disorder	2.07e-06	3.07e-06	CbGpPWpGaD
